PRELOAD PRELOAD PRELOAD PRELOAD PRELOAD

Business

Business

Providing Rapid Access to Breakthrough Therapeutics

By cultivating expertise in research, development and manufacturing and by streamlining clinical and regulatory development, BioMarin is providing rapid access to treatment and support services to patients around the world suffering from rare inherited metabolic diseases. The company has successfully developed and commercialized five products (4 approved by the FDA; 1 by the EMEA) and has formed a variety of strategic partnerships to maximize the value of both marketed products and investigational product opportunities.